Tumor suppressor miR-29c regulates radioresistance in lung cancer cells

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients

(2015) K Mavridis et al.   BRITISH JOURNAL OF CANCER

miR-15a/16 Enhances Radiation Sensitivity of Non-Small Cell Lung Cancer Cells by Targeting the TLR1/NF-κB Signaling Pathway

(2015) Fengming Lan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

(2015) Andrea Bezjak et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma

(2015) Danielle Maia et al.   Journal of Translational Medicine

Molecular Determinants of Radiation Response in Non–Small Cell Lung Cancer

(2015) Sue S. Yom et al.   SEMINARS IN RADIATION ONCOLOGY

A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1

(2015) Bo Wang et al.   Oncotarget

MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway

(2015) Jia-Quan Qu et al.   Oncotarget

Assessing the Effects of Concurrent versus Sequential Cisplatin/Radiotherapy on Immune Status in Lung Tumor-Bearing C57BL/6 Mice

(2015) C.-J. Kao et al.   Cancer Immunology Research

MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer

(2014) Xiaochun Chen et al.   BIOMEDICINE & PHARMACOTHERAPY

MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer

(2014) Haifeng Xia et al.   BIOMEDICINE & PHARMACOTHERAPY

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Role of MicroRNA in Response to Ionizing Radiations: Evidences and Potential Impact on Clinical Practice for Radiotherapy

(2014) Francesco Cellini et al.   MOLECULES

miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX

(2014) HAN-HAN ZHANG et al.   ONCOLOGY REPORTS

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer

(2014) Wangyu Zhu et al.   PLoS One

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation

(2014) P. Gasparini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13

(2014) Peijing Zhang et al.   Nature Communications

MicroRNA and signal transduction pathways in tumor radiation response

(2013) Luqing Zhao et al.   CELLULAR SIGNALLING

Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients

(2013) Min Jiang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Genome-Wide Analyses of Radioresistance-Associated miRNA Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing

(2013) Guo Li et al.   PLoS One

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

(2013) S Grosso et al.   Cell Death & Disease

MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy

(2012) Jia-Xing Zhang et al.   CANCER LETTERS

Development and characterization of an isogenic cell line with a radioresistant phenotype

(2012) Lara I. de Llobet et al.   Clinical & Translational Oncology

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients

(2012) Marek Svoboda et al.   Radiation Oncology

Lung cancer: New biological insights and recent therapeutic advances

(2011) Suresh S. Ramalingam et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNAs in Cancer

(2009) Ramiro Garzon et al.   Annual Review of Medicine

BCL-2 family antagonists for cancer therapy

(2008) Guillaume Lessene et al.   NATURE REVIEWS DRUG DISCOVERY